Tom Goodrich

Co-founder & General Partner

Tom Goodrich co-founded Corner Ventures in 2018 and is a General Partner of the firm, leading Corner’s biotech investments.

Tom is responsible for investments in Armo Biosciences (Acquired by Lilly), Atara Biotherapeutics (NASDAQ:ATRA) and Arresto Biosciences (Acquired by Gilead), Dantari Pharmaceuticals, Latigo Biotherapeutics, and Oncovalent ...


Roles at Corner Ventures

  • Co-founder & General Partner

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.